Respiratory syncytial virus (RSV) is a leading cause of lower respiratory tract infections in children under two years old, resulting in significant morbidity and a heavy economic burden on healthcare ...

A new scoping review examines the impact of respiratory bacteria on the severity of respiratory syncytial virus (RSV) ...

In addition to the cold and flu, many are falling ill to RSV, COVID and norovirus this winter. How to know what you have.

FDA 2025 pulmonology drug alerts, including drug approvals/warnings, vaccine approvals, and medical device recalls/updates.

Inhalon Biopharma, Inc. (Inhalon), a clinical-stage company advancing a first-in-class inhaled antibody platform for treating acute respiratory infections (ARI), today announced the completion of ...

In the wake of multiple cases of human metapneumovirus (hMPV) in India, multiple questions about its causes and symptoms seem ...

S-337395 is an investigational oral antiviral candidate for RSV infection that inhibits the activity of the L protein, which is essential for virus replication. 1,2 Furthermore, this drug has received ...

A bout of winter illnesses has hit the Ohio Valley School District in Adams County, district Superintendent Dawn Wallace said ...

It’s peak cold and flu season in the northern hemisphere. These respiratory viruses and other infectious pathogens are spread through close contact and/or touching contaminated surfaces. Many people ...

With the recent outbreak of norovirus cases across the country, UNC Charlotte students should be prepared and informed about ...